Senior insider sale
President, R&D & CMO at MAZE THERAPEUTICS, INC. — senior position signals high conviction
$1.83M
66.89K shares
What this filing means
BERNSTEIN HAROLD plans to sell 66.89K shares of MAZE THERAPEUTICS, INC. valued at approximately $1.83M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/4/2026ACC: 0001950047-26-009147
Officer· President, R&D & CMO
Since Mar 2026
66.89K
Shares to sell
$1.83M
Approx. market value
9.71K
Acquired (3 months)
1
Planned
4 completed
Securities Acquired — Last 3 Months1
Restricted Stock Units
N/A
9/1/2026
9.71KTotal acquired9.71K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/1/2026 | Restricted Stock Units N/A | 9.71K | — |
| Total | 9.71K | ||
Planned & Completed Dispositions5
Completed
—Completed
Units to sell
16.14K
Market value
$425.5K
9/1/2026
—Completed
Units to sell
10.29K
Market value
$270.1K
9/1/2026
—Completed
Units to sell
16.14K
Market value
$445.6K
8/13/2026
—Completed
Units to sell
14.61K
Market value
$436.9K
7/1/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
9.71K
Market value
$251.1K
9/4/2026
Total
Units
66.89K
Value
$1.83M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
9/1/2026 | 16.14K | $425.5K | — | Completed |
9/1/2026 | 10.29K | $270.1K | — | Completed |
8/13/2026 | 16.14K | $445.6K | — | Completed |
7/1/2026 | 14.61K | $436.9K | — | Completed |
| Planned — Approximate Date | ||||
9/4/2026 | 9.71K | $251.1K | NASDAQ | Planned |
| Total | 66.89K | $1.83M | ||